PETACC-8 miR-31-3p and miR-31-5p Ancillary Study

NCT03362684 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1808

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Cetuximab
DRUG: FOLFOX

Sponsor

IntegraGen SA

Collaborators

[object Object]
[object Object]